Nav: Home

Unblocking arteries after heart attack may be lifesaver for older patients

April 23, 2019

DALLAS, April 23, 2019 - Among heart attack patients 75 years and older, the oldest of those patients were less likely than younger patients to receive a procedure to open blocked arteries. But, older patients were more likely to survive heart attacks if they had the procedure, called percutaneous coronary intervention, or PCI, according to a new research letter in Circulation: Cardiovascular Interventions, an American Heart Association journal.

Adults 75 years and older are a fast-growing age group, expected to make up 11.5 percent of the U.S. population by 2050. Yet, relatively little is known about whether it's beneficial to perform PCI in these patients. PCI, also known as an angioplasty and coronary stenting, is a medical procedure in which a catheter with a deflated balloon on its tip is passed into the narrowed artery segment, the balloon is inflated and the narrowed segment widened. Then, the balloon is deflated, a stent is deployed at the site of the narrow segment, and the catheter is removed.

"We know that PCI is safe, feasible and improves overall survival and well-being in younger adults who have a heart attack," said study author Abdulla A. Damluji, M.D., M.P.H., an Assistant Professor at Johns Hopkins University School of Medicine in Baltimore, Maryland and an Interventional Cardiologist at Sinai Hospital of Baltimore, LifeBridge Health in Maryland. "But older adults tend to have more complex medical needs, and live with geriatric syndromes like frailty, multiple chronic conditions, cognitive impairment and use multiple medications. Because of these intricacies, they are systematically excluded from clinical trials to test therapies including PCI. As such, the evidence on whether or not such treatment works in older adults has not been fully evaluated."

Damluji and colleagues studied medical records of nearly 470,000 older patients admitted to U.S. hospitals with a first heart attack from 2000 to 2016. They grouped patients 75 to 79 years as "young-old," 80 to 84 as "middle-old" and 85 and older as "old-old."

They found:
  • The 85-and-older group were most likely to have other diseases when admitted for their first heart attack. They also were most likely to die in the hospital, at a rate of 13 percent, versus the youngest group of which 8 percent died in the hospital.

  • PCI was performed in 38 percent of 75- to 79-year-old group, 33 percent of the 80- to 84-year-old group and 20 percent of 85-and-older heart attack patients.

  • PCI use among 85-and-older first-time heart attack patients increased sharply over time from 10 percent in 2000 to 25 percent in 2016. Risk of death for these patients fell over time, from 17 percent in 2000 to 11 percent in 2016.

  • There was a 53 percent reduction in overall death among the 75- to 79-year-olds in the PCI group compared to the group that did not have the procedure. The reduction in death with PCI was 49 percent among those 80 to 84 and 42 percent reduction among 85-and-older. That means that for every 1,000 cases, lives were saved for 49 young-olds, 53 middle-olds and 54 old-olds.
"We are attempting PCI in the very old patient population more and more over time, and even though this is a complex patient population and PCI is an invasive intervention, it appears that the life-saving benefit is substantial," Damluji said.

"Determining through a futility assessment when a procedure should not be done remains a critical challenge" said Mauro Moscucci, M.D., M.B.A., senior author of the study and Chairman of Medicine at Sinai Hospital of Baltimore, LifeBridge Health in Maryland. "Futile procedures are procedures that are not expected to change the outcome. They can even result in worse outcomes due to unexpected complications."

A limitation of this work is it is not a clinical trial; rather, it shows an association between PCI and survival in very old adults over 85 years of age and admitted with heart attack.

"In order to have a sound conclusion about the effectiveness of PCI in this population, future clinical trials should enroll older adults even if they have complexities such as frailty, multiple chronic conditions cognitive dysfunction and multiple medications," Damluji said.
-end-
Co-authors are Jon R. Resar, M.D.; Gary Gerstenblith, M.D.; Alden L. Gross, M.H.S., Ph.D.; Daniel E. Forman, M.D.; and Mauro Moscucci, M.D., M.B.A. Author disclosures are on the manuscript.

The Johns Hopkins University Claude D. Pepper Older Americans Independence Center, National Institute on Aging and the Jane and Stanley F. Rodbell family in support of geriatric cardiology research at Sinai Hospital of Baltimore funded the study.

Additional Resources:

Available multimedia is on right column of release link - https://newsroom.heart.org/news/unblocking-arteries-after-heart-attack-may-be-lifesaver-for-older-patients?preview=1eb27198aaa643e81f2baf4bc48ff23e

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.

About the American Heart Association

The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies, and share lifesaving resources and information. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.

American Heart Association

Related Heart Attack Articles:

Where you live could determine risk of heart attack, stroke or dying of heart disease
People living in parts of Ontario with better access to preventive health care had lower rates of cardiac events compared to residents of regions with less access, found a new study published in CMAJ (Canadian Medical Association Journal).
Activated T-cells drive post-heart attack heart failure
Chronic inflammation after a heart attack can promote heart failure and death.
ICU care for COPD, heart failure and heart attack may not be better
Does a stay in the intensive care unit give patients a better chance of surviving a chronic obstructive pulmonary disease (COPD) or heart failure flare-up or even a heart attack, compared with care in another type of hospital unit?
Heart attack treatment might be in your face
Researchers at the University of Cincinnati have received $2.4 million in federal funding to pursue research on a novel cell therapy that would repair heart damage using modified cells taken from the patient's own facial muscle.
Tissue engineering advance reduces heart failure in model of heart attack
Researchers have grown heart tissue by seeding a mix of human cells onto a 1-micron-resolution scaffold made with a 3-D printer.
Study shows functional effects of human stem cell delivery to heart muscle after heart attack
Researchers delivered human stem cells seeded in biological sutures to the damaged heart muscles of rats following induced acute myocardial infarction and assessed the effects on cardiac function one week later.
Younger heart attack survivors may face premature heart disease death
For patients age 50 and younger, the risk of premature death after a heart attack has dropped significantly, but their risk is still almost twice as high when compared to the general population, largely due to heart disease and other smoking-related diseases The risk of heart attack can be greatly reduced by quitting smoking, exercising and following a healthy diet.
After the heart attack: Injectable gels could prevent future heart failure (video)
During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells in the heart.
Heart failure after first heart attack may increase cancer risk
People who develop heart failure after their first heart attack have a greater risk of developing cancer when compared to first-time heart attack survivors without heart failure, according to a study today in the Journal of the American College of Cardiology.
1 in 4 patients develop heart failure within 4 years of first heart attack
One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25,000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure by Dr.

Related Heart Attack Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...